(Q33451093)

26 July 2017

1 reference

title

Micafungin: experimental therapy of fungal infections in animal models (English)

1 reference

26 July 2017

Josep Guarro

2

0 references

author name string

Francisco Javier Pastor

series ordinal

1

1 reference

26 July 2017

publication date

1 March 2009

1 reference

Revista iberoamericana de micologia

26 July 2017

published in

1 reference

26 July 2017

volume

26

1 reference

26 July 2017

issue

1

1 reference

26 July 2017

page(s)

42-48

1 reference

In vivo pharmacodynamic target investigation for micafungin against Candida albicans and C. glabrata in a neutropenic murine candidiasis model

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2809%2970007-5

7 January 2021

Comparative efficacies of conventional amphotericin b, liposomal amphotericin B (AmBisome), caspofungin, micafungin, and voriconazole alone and in combination against experimental murine central nervous system aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2809%2970007-5

7 January 2021

Efficacy of Abelcet alone, or in combination therapy, against experimental central nervous system aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2809%2970007-5

7 January 2021

Toxicity of LY303366, an echinocandin antifungal, in mice pretreated with glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2809%2970007-5

7 January 2021

Efficacy of micafungin alone or in combination against experimental pulmonary aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2809%2970007-5

7 January 2021

Echinocandin antifungal drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2809%2970007-5

7 January 2021

Effect of amphotericin B and micafungin combination on survival, histopathology, and fungal burden in experimental aspergillosis in the p47phox-/- mouse model of chronic granulomatous disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2809%2970007-5

7 January 2021

The role of murine models in the development of antifungal therapy for systemic mycoses

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2809%2970007-5

7 January 2021

Once-weekly micafungin therapy is as effective as daily therapy for disseminated candidiasis in mice with persistent neutropenia

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2809%2970007-5

7 January 2021

Comparison of micafungin and fluconazole for experimental Candida keratitis in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2809%2970007-5

7 January 2021

The pharmacokinetics and pharmacodynamics of micafungin in experimental hematogenous Candida meningoencephalitis: implications for echinocandin therapy in neonates

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2809%2970007-5

7 January 2021

Combination echinocandin-polyene treatment of murine mucormycosis

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2809%2970007-5

7 January 2021

Efficacy of single-dose liposomal amphotericin B or micafungin prophylaxis in a neutropenic murine model of invasive pulmonary aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2809%2970007-5

7 January 2021

Comparison of the dose-dependent activity and paradoxical effect of caspofungin and micafungin in a neutropenic murine model of invasive pulmonary aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2809%2970007-5

7 January 2021

Activities of flucytosine, fluconazole, amphotericin B, and micafungin in a murine model of disseminated infection by Candida glabrata

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2809%2970007-5

7 January 2021

Combined antifungal therapy in a murine infection by Candida glabrata

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2809%2970007-5

7 January 2021

Efficacy of micafungin against deep-seated candidiasis in cyclophosphamide-induced immunosuppressed mice

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2809%2970007-5

7 January 2021

Treatment of Candida glabrata infection in immunosuppressed mice by using a combination of liposomal amphotericin B with caspofungin or micafungin

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2809%2970007-5

7 January 2021

Combined therapy in treatment of murine infection by Fusarium solani

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2809%2970007-5

7 January 2021

Efficacy of micafungin in combination with other drugs in a murine model of disseminated trichosporonosis

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2809%2970007-5

7 January 2021

Combined therapies in a murine model of blastoschizomycosis

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2809%2970007-5

7 January 2021

Micafungin combined with fluconazole, an effective therapy for murine blastoschizomycosis

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2809%2970007-5

7 January 2021

10.1016/S1130-1406(09)70007-5

Identifiers

DOI

1 reference

26 July 2017

1 reference